The study will be carried out in partnership with The GOG Foundation and the European Network of Gynaecological Oncological ...

Drs Ursula A. Matulonis and Leif W. Ellisen discuss endometrial cancer and ADCs, including resistance mechanisms, ADC sequencing, what's exciting in the field, and novel payloads.

In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 ...

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...

June is uterine cancer awareness month, one of the few cancers with a rising death rate in the U.S and researchers are working<a class="excerpt-read-more" href=" More ...

An Arkansas woman is sharing her story of becoming a new mom and beating the odds while fighting uterine cancer.

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...

Long-term results from the Women’s Health Initiative have revealed associations between cancers and hormone therapy, supplements, diet, BMI, metabolic syndrome, and NSAIDs.

Lynch syndrome is a hereditary condition that sharply raises the risk of several types of cancer. Caused by inherited ...